Laserscope designs, manufactures, sells and services on a worldwide basis
an advanced line of medical laser systems and related energy delivery
devices for the office, outpatient surgical centre, and hospital markets.
Laserscope was funded in 1984 and is a leading provider of medical laser
systems for surgical and aesthetic applications. It has over 8000 lasers
installed worldwide in doctors' offices, out-patient surgical centers and
Laserscope primarily serves the needs of two medical specialties: urology
and aesthetic surgery. Its newest product offers a breakthrough treatment
for a urological disorder called benign prostatic hyperplasia (BPH), an
enlargement of the prostate gland experienced by most men after the age of
The company has products for aesthetic applications, to perform a wide
variety of treatments including the removal of leg and facial veins,
unwanted hair, pseudo-folliculitis and wrinkles.